A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs
Until now after the human immunodeficiency virus (HIV) was discovered as the then tentative aetiological agent of acquired immune deficiency syndrome (AIDS), exactly 25 anti-HIV compounds have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories:...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Electrochemistry |
Online Access: | http://dx.doi.org/10.4061/2011/343947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552189065691136 |
---|---|
author | Burçin Bozal Bengi Uslu Sibel A. Özkan |
author_facet | Burçin Bozal Bengi Uslu Sibel A. Özkan |
author_sort | Burçin Bozal |
collection | DOAJ |
description | Until now after the human immunodeficiency virus (HIV) was discovered as the then tentative aetiological agent of acquired immune deficiency syndrome (AIDS), exactly 25 anti-HIV compounds have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, lamivudine, abacavir, stavudine, and emtricitabine), nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir), nonnucleoside reverse transcriptase inhibitors (NNRTIs: efavirenz, nevirapine, delavirdine, and etravirine), protease inhibitors (PIs: ritonavir, indinavir, saquinavir, nelfinavir, amprenavir, lopinavir, fosamprenavir, atazanavir, tipranavir and darunavir), fusion inhibitors (FIs: enfuvirtide), coreceptor inhibitors (CRIs: maraviroc), and integrase inhibitors (INIs: raltegravir). The present paper submitted the use of various electroanalytical techniques for the determination of anti-HIV drugs. This paper covers the time period from 1990 to 2010 including voltammetric techniques that were reported. Presented application concerns analysis of anti-HIV drugs from pharmaceutical dosage forms and biological samples. |
format | Article |
id | doaj-art-e2f9611a889244f292a49ee02d392420 |
institution | Kabale University |
issn | 2090-3537 |
language | English |
publishDate | 2011-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Electrochemistry |
spelling | doaj-art-e2f9611a889244f292a49ee02d3924202025-02-03T05:59:27ZengWileyInternational Journal of Electrochemistry2090-35372011-01-01201110.4061/2011/343947343947A Review of Electroanalytical Techniques for Determination of Anti-HIV DrugsBurçin Bozal0Bengi Uslu1Sibel A. Özkan2Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, 06100 Ankara, TurkeyDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, 06100 Ankara, TurkeyDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, 06100 Ankara, TurkeyUntil now after the human immunodeficiency virus (HIV) was discovered as the then tentative aetiological agent of acquired immune deficiency syndrome (AIDS), exactly 25 anti-HIV compounds have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, lamivudine, abacavir, stavudine, and emtricitabine), nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir), nonnucleoside reverse transcriptase inhibitors (NNRTIs: efavirenz, nevirapine, delavirdine, and etravirine), protease inhibitors (PIs: ritonavir, indinavir, saquinavir, nelfinavir, amprenavir, lopinavir, fosamprenavir, atazanavir, tipranavir and darunavir), fusion inhibitors (FIs: enfuvirtide), coreceptor inhibitors (CRIs: maraviroc), and integrase inhibitors (INIs: raltegravir). The present paper submitted the use of various electroanalytical techniques for the determination of anti-HIV drugs. This paper covers the time period from 1990 to 2010 including voltammetric techniques that were reported. Presented application concerns analysis of anti-HIV drugs from pharmaceutical dosage forms and biological samples.http://dx.doi.org/10.4061/2011/343947 |
spellingShingle | Burçin Bozal Bengi Uslu Sibel A. Özkan A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs International Journal of Electrochemistry |
title | A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs |
title_full | A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs |
title_fullStr | A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs |
title_full_unstemmed | A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs |
title_short | A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs |
title_sort | review of electroanalytical techniques for determination of anti hiv drugs |
url | http://dx.doi.org/10.4061/2011/343947 |
work_keys_str_mv | AT burcinbozal areviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs AT bengiuslu areviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs AT sibelaozkan areviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs AT burcinbozal reviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs AT bengiuslu reviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs AT sibelaozkan reviewofelectroanalyticaltechniquesfordeterminationofantihivdrugs |